3-Bromo-4-iodobenzonitrile
Names and Identifiers of 3-Bromo-4-iodobenzonitrile
CAS Number |
1000577-94-5 |
|---|---|
EC Number |
816-261-6 |
MDL Number |
MFCD09800817 |
IUPAC Name |
3-bromo-4-iodobenzonitrile |
InChI |
InChI=1S/C7H3BrIN/c8-6-3-5(4-10)1-2-7(6)9/h1-3H |
InChIKey |
COMRZEYMBSUAGN-UHFFFAOYSA-N |
Canonical SMILES |
C1=CC(=C(C=C1C#N)Br)I |
UNSPSC Code |
12352100 |
Physical and chemical properties of 3-Bromo-4-iodobenzonitrile
Boiling Point |
308.3±27.0°C at 760 mmHg |
|---|---|
Density |
2.31±0.1 g/cm3(Predicted) |
Exact Mass |
306.84900 |
LogP |
2.92538 |
Melting Point |
139-140 °C(Solv: ethanol (64-17-5)) |
Molecular Formula |
C7H3BrIN |
Molecular Weight |
307.91400 |
PSA |
23.79000 |
Storage condition |
2-8°C(protect from light) |
Safety Information of 3-Bromo-4-iodobenzonitrile
Applications of 3-Bromo-4-iodobenzonitrile
3-Bromo-4-iodobenzonitrile has various applications in:
- Organic Synthesis: It serves as an intermediate in the synthesis of pharmaceuticals and agrochemicals.
- Material Science: Used in the development of new materials with specific electronic or optical properties.
- Biological Research: As a tool for studying enzyme inhibition and metabolic pathways due to its interaction with cytochrome P450 enzymes.
Interaction Studies of 3-Bromo-4-iodobenzonitrile
Interaction studies involving 3-Bromo-4-iodobenzonitrile have highlighted its role as a substrate for various enzymes. Its inhibitory effects on cytochrome P450 enzymes (especially CYP1A2 and CYP2C9) indicate that it may affect the metabolism of co-administered drugs, which is crucial for understanding drug-drug interactions in pharmacotherapy.
Biological Activity of 3-Bromo-4-iodobenzonitrile
3-Bromo-4-iodobenzonitrile exhibits significant biological activity, particularly as an inhibitor of certain cytochrome P450 enzymes. Specifically, it has been identified as an inhibitor of CYP1A2 and CYP2C9, which are important for drug metabolism. These properties suggest potential applications in pharmacology and toxicology, particularly in studies involving drug interactions and metabolic pathways.
Physical sample testing spectrum (NMR) of 3-Bromo-4-iodobenzonitrile
